Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02592785 · COMPLETED
Trial details
- NCT number
- NCT02592785
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-15
- Primary completion
- 2017-02-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.